Combined Effects of Global Posture Re-education and Active Cycle of Breathing Technique in COPD
1 other identifier
interventional
68
1 country
1
Brief Summary
The randomized controlled trial will involve 30 participants, with Group A receiving GPRM and ACBT, while Group B follows the conventional COPD model that includes ACBT only.Assessments of heart rate, physical fitness, and quality of life will contribute to a nuanced understanding of joint function, informing future COPD treatment paradigms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable chronic-obstructive-pulmonary-disease
Started Mar 2024
Shorter than P25 for not_applicable chronic-obstructive-pulmonary-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 3, 2024
CompletedFirst Submitted
Initial submission to the registry
March 4, 2024
CompletedFirst Posted
Study publicly available on registry
March 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 5, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2024
CompletedJuly 23, 2024
July 1, 2024
3 months
March 4, 2024
July 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
SF- 36 Questionnaire
The 36-Item Short Form Survey (SF-36) is an outcome measure instrument that is often used, well-researched, self-reported measure of health. It stems from a study called the Medical Outcomes Study for the objective measure of the quality of life. It comprises 36 questions that cover eight domains of health: 1. Limitations in physical activities because of health problems. 2. Limitations in social activities because of physical or emotional problems 3. Limitations in usual role activities because of physical health problems 4. Bodily pain 5. General mental health (psychological distress and well-being) 6. Limitations in usual role activities because of emotional problems 7. Vitality (energy and fatigue) 8. General health perceptions Scores for the different domains are converted and pooled using a scoring key, for a total score indicating a range of low to high QOL
12 Weeks
FEV1/FVC ratio
The individual inhales maximally and then exhales forcefully into a spirometer, measuring lung volume and airflow. The procedure may be repeated multiple times to ensure accurate and consistent results.
12 Weeks
6-minute walk test
The Six-Minute Walk Test (6MWT) assesses exercise capacity. Participants are briefed and baseline vital signs are recorded. The 6 Minute Walk Test is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.
12 Weeks
Photogrammetry
Photogrammetry is a research tool used in COPD studies to assess physical changes. It involves capturing and analyzing images of patients to measure anatomical features and body movement.
12 Weeks
Forced expiratory volume (FEV1)
The individual inhales maximally and then exhales forcefully into a spirometer, measuring lung volume and airflow. The procedure may be repeated multiple times to ensure accurate and consistent results.
12 Weeks
Forced vital capacity (FVC)
The individual inhales maximally and then exhales forcefully into a spirometer, measuring lung volume and airflow. The procedure may be repeated multiple times to ensure accurate and consistent results.
12 Weeks
Study Arms (2)
Group A
EXPERIMENTALGPRM and ACBT
Group B
ACTIVE COMPARATORStandard Care for COPD (ACBT)
Interventions
Emphasizing breathing control, thoracic expansion, and mucus clearance techniques
Eligibility Criteria
You may qualify if:
- Adults aged 40-75 years diagnosed with stable COPD (according to GOLD guidelines).
- Patients of both genders
- FEV1: FVC ranging from 68 - 69%.
- Predicted FEV1 of less than 70%.
- Willingness to participate
You may not qualify if:
- Acute Exacerbation of COPD
- Participants with severe comorbidities, such as unstable cardiovascular diseases (e.g., recent myocardial infarction, uncontrolled hypertension)
- Participants diagnosed with respiratory conditions other than COPD (such as asthma, interstitial lung disease)
- Individuals who have undergone major thoracic or abdominal surgery within the past three months
- Individuals with severe mental health conditions (such as uncontrolled psychosis or severe depression)
- Pregnant or lactating individuals.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Social Security Hospital
Gujranwala, Punjab Province, 52200, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Muhammad Faizan Hamid, MS-CPPT
Riphah International University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2024
First Posted
March 13, 2024
Study Start
March 3, 2024
Primary Completion
June 5, 2024
Study Completion
June 15, 2024
Last Updated
July 23, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share